HALLANDALE BEACH, Fla.--(BUSINESS WIRE)--The Bloom Organization (“Bloom”), a national investment bank focusing exclusively on founder and physician-owned businesses in the healthcare services sector, announces the closing of its 12th M&A transaction in 2023.
With deep domain knowledge and a reputation spanning over three decades, Bloom has successfully closed hundreds of transactions, advising some of the largest independent medical practices and surgery centers in the United States. The company enters the fourth quarter having achieved $1 billion in transaction value thus far in 2023, reaching in excess of $10 billion in total completed transaction value to date. The Bloom team has advised over 5,000 physicians in achieving optimal financial and strategic outcomes, consistently delivering superior value to its clients.
Healthcare companies advised by Bloom include market participants in the following sectors:
- ENT & Allergy
- Women’s Health
- Primary Care
- Value-Based Care Networks
- Ambulatory Surgery Centers (ASCs)
- Pain Management
- Urgent Care
- Home Health & Hospice
- Behavioral Health
- Physical Therapy
- Independent Physician Associations (IPAs)
- Medical Product & Device Innovations
The healthcare space remains highly fragmented and Bloom expects continued market consolidation. We look forward to continuing to support the market in 2024 and beyond.
About The Bloom Organization
A national investment bank specializing in healthcare mergers and acquisitions, The Bloom Organization has over 30 years of experience advising physicians, group practices, ASC development companies, private equity firms, hospitals, and other healthcare operators and investors. Our clients turn to us for negotiating the strategic partnerships, joint ventures, acquisitions, leveraged buyouts, and other transactions that maximize return.